In pregnant women, does antenatal pelvic floor muscle training help to prevent urinary incontinence?

2019 ◽  
Author(s):  
Jane Burch ◽  
Sera Tort
2020 ◽  
Vol 48 (6) ◽  
pp. 030006052091422
Author(s):  
Ling Chen ◽  
Xiaomin Chen ◽  
Dan Luo ◽  
Mei Jin ◽  
Yingjie Hu ◽  
...  

Objectives We investigated performance of antenatal pelvic floor muscle training (PFMT) among Chinese pregnant women, to explore its effects on postpartum stress urinary incontinence (SUI). Methods We conducted a prospective cohort study in Shenzhen, China among 815 singleton pregnant women age ≥18 years, who were continent before pregnancy. Telephone follow-up was conducted at 6 weeks postpartum. Logistic univariable and multivariable regression analyses were used to estimate effects of antenatal PFMT (frequency and duration) on SUI postpartum among subgroups defined by SUI during pregnancy. The interactions of antenatal PFMT and PFMT duration on SUI postpartum were tested. Results Among 798 women included in the analysis, 127 (15.91%) had SUI at 6 weeks postpartum. Only 157 (19.67%) women performed antenatal PFMT, none under supervision. After adjusting potential confounders, neither frequency (odds ratio (OR) = 1.08, 95% confidence interval (CI) 0.89–1.32) nor duration (OR = 1.03, 95% CI 0.87–1.23) of antenatal PFMT was a significant factor in postpartum SUI. No interactions of antenatal PFMT and PFMT duration on SUI postpartum were found in any participants or subgroups. Conclusion No effect of self-reported, unsupervised, self-initiated antenatal PFMT on SUI 6 weeks postpartum was found. Low doses and no supervision may have contributed to the negative results.


BMJ Open ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. e039076 ◽  
Author(s):  
Sherina Mohd Sidik ◽  
Aida Jaffar ◽  
Chai Nien Foo ◽  
Noor Azimah Muhammad ◽  
Rosliza Abdul Manaf ◽  
...  

IntroductionPelvic floor muscle training (PFMT) strongly recommended to incontinent pregnant women. The Kegel Exercise Pregnancy Training-app trial is a multicentre cluster-randomised study aims to assess the effectiveness and its cost-effectiveness of the mobile app guidance in PFMT among incontinent pregnant women.Methods and analysis370 pregnant women (aged 18 years old and above) will be recruited with International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form. Ten clusters (primary care clinics) will be randomly assigned to either PFMT or usual care in a 1:1 ratio by an independent researcher (sealed envelope). The primary outcome will be urinary incontinence, and the secondary outcomes (quality of life; PFMT adherence, psychological status and mobile apps’ usability) will be assessed at four measurement time points (t0: baseline) and postintervention (t1: 4 weeks, t2: 8 weeks and t3: 8 weeks postnatal). T-test analysis will determine any significant differences at the baseline between the control and intervention groups. The mixed-model analysis will determine the effectiveness of the intervention at the population-average level for both the primary and secondary outcomes. For the cost-effectiveness analysis, expenditures during the study and 6 months after the intervention will be compared between the groups using the multiway sensitivity analysis. The recruitment planned will be in December 2020, and the planned end of the study will be in August 2021.Ethics and disseminationThis study protocol was approved by the Ethics Committee for Research Involving Human Subjects, Universiti Putra Malaysia (JKEUPM-2019–368) and Medical Research and Ethics Committee (MREC), Ministry of Health Malaysia, NMRR-19-412-47116 (IIR) with the ANZCTR registration. This study will obtain informed written consent from all the study participants. The results which conform with the Consolidated Standards of Reporting Trials and the Recommendations for Interventional Trials will be published for dissemination in peer-reviewed journals and conference proceedings.Trial registration numberACTRN12619000379112.


2021 ◽  
Vol 11 (7) ◽  
pp. 129-136
Author(s):  
Pranjal Kharde ◽  
Vishnu Vardhan

Background: Urinary incontinence is defined as the complaint of involuntary loss of urine. It is a common and embarrassing problem. Pelvic floor muscle training has been effective for the prevention and treatment of urinary incontinence during pregnancy and after childbirth. Thus, the aim of this study is to explore the effectiveness & outcome of physiotherapy in pelvic floor muscle training during pregnancy & childbirth in urinary incontinence. Methodology: In this scoping review articles are searched from the search engines like PUBMED, GOOGLE SCHOLAR, etc. These articles are reviewed according to the inclusion criteria which include articles from last 10 years, randomized control trials, systematic review, experimental study, etc. 7 articles were selected according to it. Later the qualities of these articles were analyzed using PEDRO Scale. Conclusion: In conclusion our study demonstrates that the pelvic floor muscle training might be effective in solving the problems of urinary incontinence during pregnancy and after childbirth. Pelvic floor muscle training can be advised by the physiotherapist or the pregnant women can be trained on how to perform the pelvic floor muscle exercises. Thus, pregnant women can take care of themselves and independently perform pelvic floor muscle exercises, thereby eliminating the problems of urinary incontinence. Key words: Pelvic Floor Muscle Training, Pregnancy, After Childbirth, Prevention, Treatment, Urinary Incontinence.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Lotte Firet ◽  
Theodora Alberta Maria Teunissen ◽  
Rudolf Bertijn Kool ◽  
Lukas van Doorn ◽  
Manal Aourag ◽  
...  

Abstract Background Stress urinary incontinence (SUI) is common among women and affects their quality of life. Pelvic floor muscle training is an effective conservative therapy, but only a minority of women seek help. E-health with pelvic floor muscle training is effective and increases access to care. To implement an e-Health intervention in a sustainable way, however, we need to understand what determines adoption. The aim is to investigate the barriers and facilitators to adopting an e-Health intervention among Dutch women with stress urinary incontinence. Methods Semi-structured telephonic interviews were carried out among participants of the Dutch e-Health intervention for women with stress urinary incontinence. Women were purposively sampled. The ‘Fit between Individuals, Task and Technology’ (FITT) framework was used for both the data collection and data analysis, to gain a more in-depth insight into the adoption of the intervention. Results Twenty women were interviewed, mean age 51 years and mostly highly educated. The adoption of e-Health for women with SUI mainly depends on the interaction between users and e-Health, and users and pelvic floor muscle training exercises. Facilitators for the adoption were the preference for an accessible self-management intervention, having a strong sense of self-discipline and having the ability to schedule the exercises routinely. Women needed to possess self-efficacy to do this intervention independently. Barriers to the adoption of e-Health were personal circumstances restricting time for scheduling pelvic floor muscle training and lacking skills to perform the exercises correctly. Despite guidance by technical features several women remained uncertain about their performance of the exercises and, therefore, wanted additional contact with a professional. Conclusions For stress urinary incontinence e-Health is an appropriate option for a target audience. Use of the FITT framework clearly demonstrates the conditions for optimal adoption. For a subgroup it was a suitable alternative for medical care in person. For others it identified the need for further support by a health care professional. This support could be provided by improvements of technical features and incorporating modes for digital communication. The additional value of integration of the e-Health intervention in primary care might be a logical next step. Trial registration The study was prospectively registered in the Netherlands Trial Registry (NTR) NTR6956.


Sign in / Sign up

Export Citation Format

Share Document